Moderna (MRNA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Let's look at five large-cap pharma/biotech companies slated to release quarterly results this week.
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.